EP3480307
NÝ ERFÐABREYTT KÚABÓLUEFNISVEIRA
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.5.2017EP published:
23.6.2021EP application number:
17806608.0
EP translation filed:
29.6.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
28.5.2037Expiry date:
28.5.2025
Title:
NEW GENETICALLY-MODIFIED VACCINIA VIRUS
Timeline
Today
29.5.2017EP application
23.6.2021EP Publication
29.6.2021Translation submitted
15.8.2021Registration published
28.5.2025Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411, JP
Name:
National University Corporation Tottori UniversityAddress:
101 Koyamacho-Minami 4-chome, Tottori-shi Tottori 680-8550, JP
Inventor
Name:
NAKAO, ShinsukeAddress:
Tokyo 103-8411, JP
Name:
KAWASE, TatsuyaAddress:
Tokyo 103-8411, JP
Name:
NAKAMURA, TakafumiAddress:
Yonago-shi Tottori 683-8503, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2016107481Date:
30.5.2016Country:
JP
Classification
Categories:
C12N 15/09, A61K 35/768, A61P 35/00, A61P 35/02, A61P 37/04, C12N 7/01
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.4.2022
Expires: 28.5.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.4.2023
Expires: 28.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.4.2024
Expires: 28.5.2025
Payer: Árnason Faktor ehf.